Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthcare & Medical Investment (TSE:3455) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Healthcare & Medical Investment 5-Year Yield-on-Cost % Related Terms
TSE:3455 vs WELL, VTR, DOC: 5-Year Yield-on-Cost % Comparison
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment 5-Year Yield-on-Cost % vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's 5-Year Yield-on-Cost % falls into.
Healthcare & Medical Investment 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Healthcare & Medical Investment (TSE:3455) has a 5-Year Yield-on-Cost % of 6.32 as of Sep. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Healthcare & Medical Investment and its competitors. This is 37% above median its historical median of 4.62. Over the past decade, Healthcare & Medical Investment's 5-Year Yield-on-Cost % has ranged from 3.14 to 7.45. According to the industry distribution chart, Healthcare & Medical Investment ranks #532 out of 847 companies in the REITs industry, placing it in the top 62.8%.
Is Healthcare & Medical Investment's 5-Year Yield-on-Cost % too high?
Healthcare & Medical Investment's current 5-Year Yield-on-Cost % of 6.32 is 37% above median its 10-year median of 4.62. Over the past 10 years, this metric has ranged from a low of 3.14 to a high of 7.45. The REITs industry median 5-Year Yield-on-Cost % is 7.66. Healthcare & Medical Investment's value of 6.32 is 17.5% below this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #532 out of 847 companies in the REITs industry, which is below the industry midpoint. Overall, Healthcare & Medical Investment has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's 5-Year Yield-on-Cost % compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #532 out of 847 companies for 5-Year Yield-on-Cost %. This places Healthcare & Medical Investment in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 7.66. Healthcare & Medical Investment's value of 6.32 is 17.5% below this benchmark. Historically, Healthcare & Medical Investment's own 5-Year Yield-on-Cost % has ranged from 3.14 to 7.45 over the past decade. While the company's 10-year median is 4.62 vs. the industry median of 7.66, Healthcare & Medical Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a REITs company?
The median 5-Year Yield-on-Cost % among REITs companies is 7.66, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current 5-Year Yield-on-Cost % of 6.32 is 17.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median 5-Year Yield-on-Cost % is 7.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current 5-Year Yield-on-Cost % is 6.32, which is 37% above median its own 10-year median of 4.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,510.37, compared to a current price of 円96,100.00 — trading 25.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.32, which is 37% above median its 10-year median of 4.62 and 17.5% below the REITs industry median of 7.66. Healthcare & Medical Investment's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current 5-Year Yield-on-Cost % is 6.32 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円96,100.00 is trading 25.8% below its estimated GF Value™ of 円129,510.37.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
5-Year Yield-on-Cost %: 6.32 (37% above median its 10-year median of 4.62)
GF Value™: 円129,510.37 vs. price of 円96,100.00 (25.8% below fair value)
Industry Position: 17.5% below the REITs median (#532 of 847)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
50GF Score
Get the complete analysis for TSE:3455
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
